These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 19437467
1. Design and discovery of plasmepsin II inhibitors using an automated workflow on large-scale grids. Degliesposti G, Kasam V, Da Costa A, Kang HK, Kim N, Kim DW, Breton V, Kim D, Rastelli G. ChemMedChem; 2009 Jul; 4(7):1164-73. PubMed ID: 19437467 [Abstract] [Full Text] [Related]
7. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors. Ferrari AM, Degliesposti G, Sgobba M, Rastelli G. Bioorg Med Chem; 2007 Dec 15; 15(24):7865-77. PubMed ID: 17870536 [Abstract] [Full Text] [Related]
9. Search for substrate-based inhibitors fitting the S2' space of malarial aspartic protease plasmepsin II. Kiso A, Hidaka K, Kimura T, Hayashi Y, Nezami A, Freire E, Kiso Y. J Pept Sci; 2004 Nov 15; 10(11):641-7. PubMed ID: 15568678 [Abstract] [Full Text] [Related]
14. Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residues. Xie D, Gulnik S, Collins L, Gustchina E, Suvorov L, Erickson JW. Biochemistry; 1997 Dec 23; 36(51):16166-72. PubMed ID: 9405050 [Abstract] [Full Text] [Related]
15. Pyrrolidine derivatives as plasmepsin inhibitors: binding mode analysis assisted by molecular dynamics simulations of a highly flexible protein. Luksch T, Blum A, Klee N, Diederich WE, Sotriffer CA, Klebe G. ChemMedChem; 2010 Mar 01; 5(3):443-54. PubMed ID: 20112327 [Abstract] [Full Text] [Related]
19. Molecular dynamics simulations of the three dimensional model of plasmepsin II-peptidic inhibitor complexes. Pranav Kumar SK, Kulkarni VM. Drug Des Discov; 2001 Mar 01; 17(4):293-313. PubMed ID: 11765133 [Abstract] [Full Text] [Related]